Want to see KNSA full AI Analyst Report?
Kiniksa Pharmaceuticals (KNSA) Ownership Overview
6.93% Insiders
23.16% Mutual Funds
32.58% Other Institutional Investors
14.31% ETFs
23.02% Public Companies and
Individual Investors
The ownership structure of Kiniksa Pharmaceuticals (KNSA) stock is a mix of institutional, retail, and individual investors. Approximately 70.05% of the company’s stock is owned by Institutional Investors, 6.93% is owned by Insiders, and 23.02% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 31, 2026 | xxxxxxxxxxxxx | $299092 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $181275420 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $45928826 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $25469111 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,280,350 | Institution | 6.79% | 257,573,082 | |
| 2,834,643 | Institution | 5.87% | 222,576,168 | |
| 2,775,939 | Institution | 5.75% | 217,966,730 | |
| 2,774,574 | Insider | 5.75% | 217,859,550 | |
| 1,739,230 | Institution | 3.60% | 136,564,340 | |
| 1,319,688 | Institution | 2.73% | 103,621,902 | |
| 1,169,874 | Institution | 2.42% | 91,858,506 | |
| 1,067,500 | Institution | 2.21% | 83,820,100 | |
| 817,600 | Institution | 1.69% | 64,197,952 | |
| 757,043 | Institution | 1.57% | 59,443,016 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,775,939 | Institution | 5.75% | 217,966,730 | |
| 1,169,874 | Institution | 2.42% | 91,858,506 | |
| 1,067,500 | Institution | 2.21% | 83,820,100 | |
| 817,600 | Institution | 1.69% | 64,197,952 | |
| 603,640 | Institution | 1.25% | 47,397,813 | |
| 522,983 | Institution | 1.08% | 41,064,625 | |
| 422,472 | Institution | 0.87% | 33,172,501 | |
| 389,911 | Institution | 0.81% | 30,615,812 | |
| 349,921 | Institution | 0.72% | 27,475,797 | |
| 332,730 | Institution | 0.69% | 26,125,960 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,324,057 | Institution | 2.74% | 98,430,397 | |
| 1,077,167 | Institution | 2.23% | 84,579,153 | |
| 955,916 | Institution | 1.98% | 61,130,828 | |
| 553,469 | Institution | 1.15% | 41,144,885 | |
| 397,497 | Institution | 0.82% | 31,211,464 | |
| 237,878 | Institution | 0.49% | 17,683,851 | |
| 150,789 | Institution | 0.31% | 11,624,324 | |
| 146,157 | Institution | 0.30% | 9,346,740 | |
| 140,266 | Institution | 0.29% | 10,813,106 | |
| 140,266 | Institution | 0.29% | 10,813,106 |
FAQ
Who Owns Kiniksa Pharmaceuticals (KNSA)?
According to the latest TipRanks data, approximately 32.58% of the company's stock is held by institutional investors, 6.93% is held by insiders, and 23.02% is held by retail investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.58% of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.02% of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors.
Who owns the most shares of Kiniksa Pharmaceuticals (KNSA)?
Vanguard owns the most shares of Kiniksa Pharmaceuticals (KNSA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.